Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Wunderlich

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Experimental Hematology|August 21, 2018
Comparative utility of NRG and NRGS mice for the study of normal hematopoiesis, leukemogenesis, and therapeutic responseAditya Barve, Lavona Casson, Maxwell Krem, et al.
Blood|April 30, 2014
OKT3 prevents xenogeneic GVHD and allows reliable xenograft initiation from unfractionated human hematopoietic tissuesMark Wunderlich, Ryan A Brooks, Rushi Panchal, et al.
Blood Advances|November 12, 2021
Momelotinib is a highly potent inhibitor of FLT3-mutant AMLMohammad Azhar, Zachary Kincaid, Meenu Kesarwani, et al.
Blood|January 26, 2013
AML cells are differentially sensitive to chemotherapy treatment in a human xenograft modelMark Wunderlich, Benjamin Mizukawa, Fu-Sheng Chou, et al.
Plos One|December 13, 2018
Improved multilineage human hematopoietic reconstitution and function in NSGS miceMark Wunderlich, Fu-Sheng Chou, Christina Sexton, et al.
Mutation Research|June 11, 2013
The rate of spontaneous mutations in human myeloid cellsDavid J Araten, Ondrej Krejci, Kimberly Ditata, et al.
JCI Insight|October 5, 2016
A xenograft model of macrophage activation syndrome amenable to anti-CD33 and anti-IL-6R treatmentMark Wunderlich, Courtney Stockman, Mahima Devarajan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2016
Supraphysiologic levels of the AML1-ETO isoform AE9a are essential for transformationKevin A Link, Shan Lin, Mahesh Shrestha, et al.
Blood|November 3, 2007
p53 signaling in response to increased DNA damage sensitizes AML1-ETO cells to stress-induced deathOndrej Krejci, Mark Wunderlich, Hartmut Geiger, et al.
Cells|November 14, 2019
Perturbation of Methionine/S-adenosylmethionine Metabolism as a Novel Vulnerability in MLL Rearranged LeukemiaAditya Barve, Alexis Vega, Parag P Shah, et al.
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Experimental Hematology|August 21, 2018
Comparative utility of NRG and NRGS mice for the study of normal hematopoiesis, leukemogenesis, and therapeutic responseAditya Barve, Lavona Casson, Maxwell Krem, et al.
Blood|April 30, 2014
OKT3 prevents xenogeneic GVHD and allows reliable xenograft initiation from unfractionated human hematopoietic tissuesMark Wunderlich, Ryan A Brooks, Rushi Panchal, et al.
Blood Advances|November 12, 2021
Momelotinib is a highly potent inhibitor of FLT3-mutant AMLMohammad Azhar, Zachary Kincaid, Meenu Kesarwani, et al.
Blood|January 26, 2013
AML cells are differentially sensitive to chemotherapy treatment in a human xenograft modelMark Wunderlich, Benjamin Mizukawa, Fu-Sheng Chou, et al.
Plos One|December 13, 2018
Improved multilineage human hematopoietic reconstitution and function in NSGS miceMark Wunderlich, Fu-Sheng Chou, Christina Sexton, et al.
Mutation Research|June 11, 2013
The rate of spontaneous mutations in human myeloid cellsDavid J Araten, Ondrej Krejci, Kimberly Ditata, et al.
JCI Insight|October 5, 2016
A xenograft model of macrophage activation syndrome amenable to anti-CD33 and anti-IL-6R treatmentMark Wunderlich, Courtney Stockman, Mahima Devarajan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2016
Supraphysiologic levels of the AML1-ETO isoform AE9a are essential for transformationKevin A Link, Shan Lin, Mahesh Shrestha, et al.
Blood|November 3, 2007
p53 signaling in response to increased DNA damage sensitizes AML1-ETO cells to stress-induced deathOndrej Krejci, Mark Wunderlich, Hartmut Geiger, et al.
Cells|November 14, 2019
Perturbation of Methionine/S-adenosylmethionine Metabolism as a Novel Vulnerability in MLL Rearranged LeukemiaAditya Barve, Alexis Vega, Parag P Shah, et al.
Pageof 12